Section 2.4.
To the extent not paid to Purchaser pursuant to
Section 2.4, such amount shall be released to the Seller Representative (on
behalf of the Sellers and the Remaining Members) following the written direction
of the Seller Representative, no later than the third (3rd) Business Day
following the determination of the Final Closing Transaction Value pursuant to
Section 2.4.
(b)
Each of the following terms is defined in
the Section set forth opposite such term:
Term
Article, Section (or Schedule)
Accrued Bonus Obligations
7.5(f)
Acquired Business Contractors
3.9(a)
Acquired Business Employees
3.9(a)
Acquired Business Sales Revenue
2.5(a)
Agreement
Preamble
Allocable Merger Consideration
2.2(b)(i)
Asset and Liability Allocation Agreement
Recitals
Audit Period
2.5(g)
Available First 12 Month Basket
8.7(b)
Benefit Transition Period
7.5(c)
14
Claim
8.5(a)
Claim Certificate
8.5(a)
Claim Dispute Notice
8.5(b)
Closing
2.3(a)
Closing Cash
Schedule 2.1(b)
Closing Date
2.3(a)
Closing Net Working Capital
Schedule 2.1(b)
COBRA
3.9(c)
Consenting Parent Equity Holders
Preamble
Company
Preamble
Company 401(k) Plan
7.5(c)
Company LLC Agreement
2.9
Company Organizational Documents
3.1
Company Pre-Closing Certificate
2.1(b)
Competitive Business
6.1(a)
Covered Employees
7.5(c)
Current Assets
Schedule 2.1(b)
Current Liabilities
Schedule 2.1(b)
Domestic Transition Services Agreement
Recitals
Earnout Amount
2.5(a)
Earnout Payment Date
8.7(a)
Earnout Period
2.5(a)
EEA
3.12(k)
Effective Time
2.2(a)
Employment Agreements
Recitals
Environmental Permits
3.16(b)
Estimated Closing Cash
2.1(b)
Estimated Closing Transaction Value
2.1(b)
Estimated Merger Consideration
2.1(b)
Estimated Purchase Price
2.1(b)
Estimated Working Capital Adjustment
2.1(b)
Excess First 12 Month Earnout Deposits
8.7(b)
Export and Import Approvals
3.12(j)
Export and Import Laws
3.12(j)
FCPA
3.12(h)
FDA
3.12(a)
Final Closing Transaction Value
2.4(a)
Final Closing Transaction Value Schedule
2.4(a)
First 12 Month Earnout Claim Cap
8.7(b)
First 12 Month Specified Portion
8.7(b)
FMLA
3.9(c)
Foreign Plan
3.9(p)
General Indemnity Threshold
8.2(a)
Health Care Law
3.12(a)
HIPAA
3.12(a)
15
Historical Books and Records
7.4(a)
Holder Group
7.7
Indemnified Persons
7.3(a)
Independent Accounting Firm
2.4(b)
Initial Allocable Merger Consideration
2.2(c)
Intellectual Property Cross-License Agreements
Recitals
Leased Real Property Leases
3.18(c)
Malicious Code
3.11(m)
Material Contracts
3.13(a)
Maximum Earnout Amount
2.5(a)
Merger
Recitals
Merger Closing
2.3(a)
Net Working Capital Baseline
Schedule 2.1(b)
Non-Compete Period
6.1(a)
Other Claims
8.7(c)
Other Earnout Claim Cap
8.7(d)
Other Specified Portion
8.7(d)
Parent
Preamble
Parent Sub
Preamble
Pre-Closing Reorganization
Recitals
Pre-Closing Reorganization Documents
Recitals
Pre-Closing Tax Returns
9.2(a)
Prior Excess First 12 Month Earnout Deposit
8.7(b)
Proposed Final Closing Transaction Value
2.4(a)
Purchase Price
2.1(a)
Purchaser
Preamble
Purchaser Earnout Certificate
2.5(c)
Regulatory Permits
3.12(b)
Related Party
3.17
Remaining Member
Recitals
Remaining Parent Equity Holders
7.9
Restricted Party
6.1(a)
Retained Employees
7.5(g)
Retained Marks
7.8(a)
Safety Notices
3.12(e)
Share Sale
Recitals
Share Sale Closing
2.3(a)
Seller or Sellers
Preamble
Seller Fundamental Representations
8.1(a)
Seller Repping Party
Article IV
Seller Representative
Preamble
Seller Represented Parties
6.2(a)
Specified Accounting Principles
Schedule 2.1(b)
Swiss Sublease
Recitals
Tail Policy
7.3(b)
Third Party Claim
8.6
16
Transaction Value
2.1(a)
Transition Services Agreements
Recitals
Transitory Subsidiary
Preamble
Uncovered First 12 Month Claim Amount
8.7(a)
Uncovered Other Claim Amount
8.7(c)
Working Capital Adjustment
Schedule 2.1(b)